Lakefront Biotherapeutics (GLPGF) Goodwill (2013 - 2025)

Lakefront Biotherapeutics (GLPGF) has reported Goodwill for 6 consecutive years, with $78.3 million the latest figure, recorded in Q2 2025.

• On a quarterly basis, Goodwill changed N/A year-over-year to $78.3 million in Q2 2025; TTM through Jun 2025 was $78.3 million, a N/A change from a year earlier, with the FY2024 full-year figure at $75.8 million, up 1.25% from the prior year.
• Goodwill was $78.3 million for Q2 2025 at Lakefront Biotherapeutics, up from $73.3 million in the prior quarter.
• Over five years, Goodwill peaked at $78.3 million in Q2 2025 and troughed at $71.2 million in Q4 2022.
• A 4-year average of $75.0 million and a median of $74.8 million in 2023 frame the typical range for Goodwill.
• Across the five-year window, Goodwill increased 5.07% in 2023 and slipped 3.18% in 2025, its largest moves.
• Over 4 years, Goodwill stood at $71.2 million in 2022, then climbed by 5.07% to $74.8 million in 2023, then declined by 0.04% to $74.8 million in 2024, then gained by 4.63% to $78.3 million in 2025.
• The last three Goodwill figures came in at $78.3 million (Q2 2025), $73.3 million (Q1 2025), and $74.8 million (Q4 2024), per Business Quant data.